These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 66905)

  • 1. [The H-2 complex, tumor antigens and/or virus-induced antigens].
    Levy JP
    Ann Immunol (Paris); 1977; 128(1-2):493-505. PubMed ID: 66905
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 3. Central problems in tumor immunology, 1976.
    Weiss DW
    Isr J Med Sci; 1976; 12(4-5):281-7. PubMed ID: 1084878
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and viral interactions of H-2 antigens.
    Cunningham BA; Reske K; Milner RJ; Schrader JW; Ziffer JA
    Birth Defects Orig Artic Ser; 1978; 14(2):203-16. PubMed ID: 76484
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 8. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of H-2 antigens in the cytolysis of Oncornavirus induced tumour cells by syngeneic T lymphocytes [proceedings].
    Gomard E; Duprez V; Henin Y; Levy JP
    Folia Biol (Praha); 1976; 22(6):387-8. PubMed ID: 1087248
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic interactions of virus-specific effector cells with virus-infected targets of different cell type [proceedings].
    Koszinowski U; Ertl H
    Folia Biol (Praha); 1976; 22(6):397. PubMed ID: 1087249
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of immunoregulatory responses directed toward various tumor antigens within hosts possessing distinct immunologic potentials.
    Roberts LK; Spellman CW; Daynes RA
    J Immunol; 1980 Aug; 125(2):663-72. PubMed ID: 6156212
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition and destruction of target cells by tumoricidal macrophages.
    Fidler IJ
    Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology of virus-induced tumours.
    Sjögren HO
    Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chicken RNA tumor viruses: a model for virus-induced carcinogenesis].
    Bauer H; Bolognesi DP; Gelderblom H; Graf T; Kurth R; Mölling K
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):66-78. PubMed ID: 4145639
    [No Abstract]   [Full Text] [Related]  

  • 15. [New aspects of tumor immunology. Importance of the T-cell system].
    Knuth A; Dippold W; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1982 Jul; 107(28):1105-10. PubMed ID: 6177489
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
    Treves AJ; Schechter B; Cohen IR; Feldman M
    J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathology of polyoma-induced tumors.
    Vandeputte M
    Springer Semin Immunopathol; 1982; 4(4):317-32. PubMed ID: 6293109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.